148 related articles for article (PubMed ID: 3391814)
1. Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds.
Luxton G; Astrahan MA; Liggett PE; Neblett DL; Cohen DM; Petrovich Z
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):167-76. PubMed ID: 3391814
[TBL] [Abstract][Full Text] [Related]
2. Dosimetry and physical treatment planning for iodine eye plaque therapy.
Alberti W; Pothmann B; Tabor P; Muskalla K; Hermann KP; Harder D
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1087-92. PubMed ID: 2022510
[TBL] [Abstract][Full Text] [Related]
3. An iodine-125 plaque for radiotherapy of the eye: manufacture and dosimetric considerations.
Harnett AN; Thomson ES
Br J Radiol; 1988 Sep; 61(729):835-8. PubMed ID: 3242502
[TBL] [Abstract][Full Text] [Related]
4. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
Nath R; Meigooni AS; Muench P; Melillo A
Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
[TBL] [Abstract][Full Text] [Related]
5. The dosimetry of 125I seed eye plaques.
Weaver KA
Med Phys; 1986; 13(1):78-83. PubMed ID: 3814235
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry for 125I seed (model 6711) in eye plaques.
Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
[TBL] [Abstract][Full Text] [Related]
8. Backscatter measurements from a single seed of 125I for ophthalmic plaque dosimetry.
Luxton G; Astrahan MA; Petrovich Z
Med Phys; 1988; 15(3):397-400. PubMed ID: 3405144
[TBL] [Abstract][Full Text] [Related]
9. Dose parameters of 125I and 192Ir seed sources.
Weaver KA; Smith V; Huang D; Barnett C; Schell MC; Ling C
Med Phys; 1989; 16(4):636-43. PubMed ID: 2770636
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
Knutsen S; Hafslund R; Monge OR; Valen H; Muren LP; Rekstad BL; Krohn J; Dahl O
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1159-66. PubMed ID: 11704341
[TBL] [Abstract][Full Text] [Related]
11. 125I eye plaque dose distribution including penumbra characteristics.
de la Zerda A; Chiu-Tsao ST; Lin J; Boulay LL; Kanna I; Kim JH; Tsao HS
Med Phys; 1996 Mar; 23(3):407-18. PubMed ID: 8815384
[TBL] [Abstract][Full Text] [Related]
12. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
Bard JJ
Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
[TBL] [Abstract][Full Text] [Related]
13. An interactive treatment planning system for ophthalmic plaque radiotherapy.
Astrahan MA; Luxton G; Jozsef G; Kampp TD; Liggett PE; Sapozink MD; Petrovich Z
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):679-87. PubMed ID: 2318702
[TBL] [Abstract][Full Text] [Related]
14. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
16. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source.
Karaiskos P; Angelopoulos A; Sakelliou L; Sandilos P; Antypas C; Vlachos L; Koutsouveli E
Med Phys; 1998 Oct; 25(10):1975-84. PubMed ID: 9800706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
